Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Current Problems in Cardiology(1)
International Journal of Stroke(1)
JAMA Neurology(1)
Stroke(1)
The Lancet(1)
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation
ReviewAbstract: Hypertension is a leading risk factor for disease burden globally. An unresolved question is whetherPalabras claves:Autores:Aguirre-Palacios F., Alcocer L., Barbosa E.C.D., Bertomeu-Martinez V., Bryce-Moncloa A., Burrell L.M., Coca A., Duenas-Herrera A., Kones R., Lanas F., Landrove O., Lavie C.J., Machado C.A., Morales Salinas A., Olsen M.H., Ordunez P., Orias M., Ortellado J., Parra-Carrillo J.Z., PATRICIO LOPEZ -JARAMILLO, Perez G., Pineiro D.J., Piskorz D.L., Prabhakaran D., Ramírez A.J., Redon J., Rodriguez Portelles A., Rodriguez-Leyva D., Sabio R., Sanchez R.A., Schutte A.E., Sebba-Barroso W.K., Sobrino J., Sundström J., Ventura H., Waisman G., Wang J.G., Weber M.A., Yano Y., Yusuf S., Zanchetti A.Fuentes:googlescopusA call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
ReviewAbstract:Palabras claves:Autores:Angell S.Y., Asma S., Boutouyrie P., Burger D., Chirinos J.A., Damasceno A., Delles C., Gimenez-Roqueplo A.P., Hering D., Martinez F., Olsen M.H., PATRICIO LOPEZ -JARAMILLO, Perkovic V., Rietzschel E.R., Schillaci G., Schutte A.E., Scuteri A., Sharman J.E., Wachtell K., Wang J.G.Fuentes:googlescopusApplicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry
ArticleAbstract: Background: Randomized controlled trials provide high-level evidence, but the necessity to include sPalabras claves:acute ischemic stroke, Alteplase, Clinical trial, health outcomes, thrombolysisAutores:Arima H., Bath P.M.W., Bray B.D., Broderick J.P., Chalmers J., Durham A.C., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Paley L., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Rudd A.G., S Anderson C., Sharma V.K., Sprigg N., Wang J.G., Wang X., Woodward M.Fuentes:scopusLow-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)
Conference ObjectAbstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior aPalabras claves:aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activatorAutores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.Fuentes:scopusLow-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial
ArticleAbstract: IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the stPalabras claves:Autores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopus